Consilium MedicumConsilium Medicum2075-17532542-2170Consilium Medicum9529810.26442/20751753.2020.10.200291MiscellaneousClinical case of successful use of non-invasive ventilation in a patient with a new coronavirus infectionLitvinAleksandr Yu.alelitvin@yandex.ruElfimovaEvgeniia M.-MikhailovaOksana O.-AlekseevaTatiana A.-SivakovaOlga A.-DanilovNikolai M.-PevznerDmitrii V.-DulaevLavrentii O.-ZyuryaevIlia T.-GamanSvetlana A.-National Medical Research Center for CardiologyPirogov Russian National Research Medical University151020202210232828122021Copyright © 2020, Consilium Medicum2020The new coronavirus disease COVID-19 (SARS-CoV-2) is a challenge both in terms of optimal patient management and the protection of the medical personnel. We present a clinical case of a 49-year-old patient with bilateral polysegmental pneumonia (COVID-19), complicated by acute respiratory distress syndrome and a cytokine storm, in whom the chosen treatment tactics using non-invasive ventilation allowed avoidance of intubation together with organization of sufficient protection for medical personnel.COVID-19non-invasive ventilationCOVID-19new coronavirus infectionpneumoniarespiratory supportнеинвазивная вентиляция легкихновая коронавирусная инфекцияпневмонияреспираторная поддержка[Guan W, Ni Z, Hu Y et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med 2020; 382: 1708-20. DOI: 10.1056/NEJMoa2002032][Wang D, Hu B, Hu C et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020. DOI: 10.1001/jama.2020.1585][Hernandez AV, Roman YM, Pasupuleti V et al. Hydroxychloroquine or Chloroquine for Treatment or Prophylaxis of COVID-19: A Living Systematic Review. Ann Intern Med 2020; 10.7326/M20-2496. DOI: 10.7326/M20-2496][Cao B, Wang Y, Wen D et al. A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19. N Engl J Med 2020; 382 (19): 1787-99. DOI: 10.1056/NEJMoa2001282][Alattar R, Ibrahim TBH, Shaar SH et al. Tocilizumab for the treatment of severe COVID-19. J Med Virol 2020; 1-8. DOI: 10.1002/jmv.25964][Michot JM, Albiges L, Chaput N et al. Tocilizumab, an anti-IL6 receptor antibody, to treat Covid-19-related respiratory failure: a case report. Ann Oncol 2020. DOI: 10.1016/j.annonc.2020.03.300.][Lillicrap D. Disseminated intravascular coagulation in patients with 2019-nCoV pneumonia. J Thromb Haemost 2020. DOI: 10.1111/jth.14781][Zhang Y, Xiao M, Zhang S et al. Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19. N Engl J Med 2020. DOI: 10.1056/NEJMc2007575][Huang C, Wang Y, Li X et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395: 497-506. DOI: 10.1016/S0140-6736(20)30183-5][Brochard L, Slutsky A, Pesenti A. Mechanical ventilation to minimize progression of lung injury in acute respiratory failure. Am J Respir Crit Care Med 2017; 195 (4): 438-42. DOI: 10.1164/rccm.201605-1081CP][Marini JJ, Gattinoni L. Management of COVID-19 Respiratory Distress. JAMA 2020. DOI: 10.1001/jama.2020.6825][Nicolini A, Cilloniz C, Piroddi IG et al. Noninvasive ventilation for acute respiratory failure due to community-acquired pneumonia: A concise review and update. Community Acquired Infection 2015; 2 (2): 46. DOI: 10.4103/2225-6482.159224][Yang X, Yu Y, Xu J et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med 2020. DOI: 10.1016/S2213-2600(20)30079-5][Tran K, Cimon K, Severn M et al. Aerosol generating procedures and risk of transmission of acute respiratory infections to healthcare workers: a systematic review. PLoS One 2012; 7: e35797. DOI: 10.1371/journal.pone.0035797. PMID: 22563403.][Hui DS, Chow BK, Lo T et al. Exhaled air dispersion during high-flow nasal cannula therapy versus CPAP via different masks. Eur Respir J 2019; 53 (4): 1802339. DOI: 10.1183/13993003.02339-2018][Simonds AK, Hanak A, Chatwin M et al. Evaluation of droplet dispersion during non-invasive ventilation, oxygen therapy, nebuliser treatment and chest physiotherapy in clinical practice: implications for management of pandemic influenza and other airborne infections. Health Technol Assess 2010; 14 (46): 131-72. DOI: 10.3310/hta14460-02][Nicas M, Nazaroff WW, Hubbard A. Toward understanding the risk of secondary airborne infection: emission of respirable pathogens. J Occup Environ Hyg 2005; 2 (3): 143-54. DOI: 10.1080/15459620590918466][Bourouiba L. Turbulent Gas Clouds and Respiratory Pathogen Emissions: Potential Implications for Reducing Transmission of COVID-19. JAMA 2020; 10.1001/jama.2020.4756. DOI: 10.1001/jama.2020.4756. PMID: 32215590][NHS (2020). Guidance for the role and use of non-invasive respiratory support in adult patients with coronavirus (confirmed or suspected). 2020 March 26.][Seto WH, Tsang D, Yung RW et al. Effectiveness of precautions against droplets and contact in prevention of nosocomial transmission of severe acute respiratory syndrome (SARS). Lancet 2003; 361: 1519-20. DOI: 10.1016/s0140-6736(03)13168-6]